Showing 1 - 8 results of 8 for search 'Elisabetta Tedone', query time: 0.04s
Refine Results
-
1
P530: CPX-351 INDUCTION IS ABLE TO INDUCE MRD NEGATIVE CR IN A SIGNIFICATIVE PROPORTION OF VERY HIGH RISK AML PATIENTS, REGARDLESS OF MUTATIONAL BURDEN, ALLOWING FOR BRIDGING TO TR... by Carola Riva, Maria Chies, Paola Minetto, Chiara Vernarecci, Elena Maio, Beatrice Ferro, Giada Zecchetti, Maurizio Miglino, Elisabetta Tedone, Nicoletta Colombo, Enrico Carminati, Clara Nurra, Francesco Puglisi, Antonia Cagnetta, Michele Cea, Roberto Massimo Lemoli, Fabio Guolo
Published 2023-08-01
Article -
2
PB1742: FEASIBILITY AND EFFICACY OF A PEG-ASPARAGINASE-BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS by Chiara Vernarecci, Beatrice Ferro, Francesco Puglisi, Clara Nurra, Enrico Carminati, Carola Riva, Maria Chies, Elena Maio, Giada Zecchetti, Maurizio Miglino, Nicoletta Colombo, Filippo Ballerini, Antonia Cagnetta, Michele Cea, Elisabetta Tedone, Fabio Guolo, Paola Minetto, Roberto Massimo Lemoli
Published 2023-08-01
Article -
3
Early CAR− CD4+ T‐lymphocytes recovery following CAR‐T cell infusion: A worse outcome in diffuse large B cell lymphoma by Massimiliano Gambella, Simona Carlomagno, Rosa Mangerini, Nicoletta Colombo, Alessia Parodi, Chiara Ghiggi, Livia Giannoni, Elisa Coviello, Chiara Setti, Silvia Luchetti, Alberto Serio, Antonella Laudisi, Monica Passannante, Alessandra Bo, Elisabetta Tedone, Simona Sivori, Emanuele Angelucci, Anna Maria Raiola
Published 2024-04-01
Article -
4
P381: FULL PEDIATRIC INDUCTION IN ADULTS AGED UP TO 55 YEARS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IS WELL TOLERATED AND RESULTS IN VERY HIGH CURE RATE by Elena Maio, Mattia Montanari, Francesco Puglisi, Clara Nurra, Maurizio Miglino, Nicoletta Colombo, Enrico Carminati, Giada Zecchetti, Chiara Vernarecci, Maria Chies, Beatrice Ferro, Massimo Zucchetti, Antonia Cagnetta, Michele Cea, Elisabetta Tedone, Roberto Massimo Lemoli, Fabio Guolo, Paola Minetto
Published 2023-08-01
Article -
5
S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATE... by Fabio Guolo, Paola Minetto, Silvia Pesce, Filippo Ballerini, Michele Cea, Marco Greppi, Matteo Bozzo, Maurizio Miglino, Elisabetta Tedone, Alessandra Bo, Alberto Serio, Silvia Luchetti, Simona Candiani, Marco Mora, Vanessa Agostini, Paolo Nozza, Genny Del Zotto, Emanuela Marcenaro, Roberto Massimo Lemoli
Published 2023-08-01
Article -
6
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy by Chiara Dentone, Antonio Vena, Maurizio Loconte, Federica Grillo, Iole Brunetti, Emanuela Barisione, Elisabetta Tedone, Sara Mora, Antonio Di Biagio, Andrea Orsi, Andrea De Maria, Laura Nicolini, Lorenzo Ball, Daniele Roberto Giacobbe, Laura Magnasco, Emanuele Delfino, Luca Mastracci, Rosa Mangerini, Lucia Taramasso, Chiara Sepulcri, Rachele Pincino, Martina Bavastro, Matteo Cerchiaro, Malgorzata Mikulska, Bianca Bruzzone, Giancarlo Icardi, Paolo Frisoni, Angelo Gratarola, Nicolò Patroniti, Paolo Pelosi, Matteo Bassetti
Published 2021-04-01
Article -
7
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation o... by Fabio Guolo, Fabio Guolo, Paola Minetto, Silvia Pesce, Filippo Ballerini, Marino Clavio, Michele Cea, Michele Cea, Michela Frello, Matteo Garibotto, Marco Greppi, Matteo Bozzo, Matteo Bozzo, Maurizio Miglino, Maurizio Miglino, Monica Passannante, Riccardo Marcolin, Elisabetta Tedone, Nicoletta Colombo, Rosa Mangerini, Alessandra Bo, Maria Rosaria Ruzzenenti, Paolo Carlier, Alberto Serio, Silvia Luchetti, Alida Dominietto, Riccardo Varaldo, Simona Candiani, Vanessa Agostini, Jean Louis Ravetti, Genny Del Zotto, Emanuela Marcenaro, Roberto Massimo Lemoli, Roberto Massimo Lemoli
Published 2021-11-01
Article -
8
P553: PRELIMINARY RESULTS OF MRD ANALYSIS OF AML1718, A PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, IDARUBICIN AND CYTARABINE (V-FLAI) IN THE INDUCTION THERAPY OF NON LOW-... by Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara DI Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adrianno Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto Massimo Lemoli
Published 2023-08-01
Article